Raddium RA223 dichloride radiotheropeutic pharmaceatical
Ended Awarded
- Contract number
- HT009021FG0510008
- Awardee
-
Cardinal Health 414, LLC UEI CWN9UGL3NCL9 Part of Cardinal Health, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $12,714
Award facts
- Contract value 100% obligated
- $12,714.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Dublin, OH 43017, USA
Award details come from SAM.gov/FPDS.
About this award
Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., has been awarded a firm fixed-price contract by the Defense Health Agency to deliver radiotherapeutic pharmaceutical RADDIUM RA223 DICHLORIDE. The $12,714.06 contract was issued through the Basic Purchasing Agreement call and has a completion date of September 30, 2021. Performance will take place in Dublin, Ohio. No set-aside designation was applied to this procurement for the requested radiotherapeutic product.
Quick answers
Who was awarded contract HT009021FG0510008?
HT009021FG0510008 was awarded to Cardinal Health 414, LLC by Defense Health Agency (Department of Defense) on May 6, 2021.
How much is contract HT009021FG0510008 worth?
The government has obligated $12,714 on HT009021FG0510008.
Is contract HT009021FG0510008 an order under another contract?
Yes. HT009021FG0510008 is a BPA call under HT001420A0031, a blanket purchase agreement.
Was contract HT009021FG0510008 competed?
The extent of competition for HT009021FG0510008 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award